Fatty Acids and Outcomes in Lupus Patients
Author Information
Author(s): Gilley Kristen N., Fenton Jenifer I., Zick Suzanna M., Li Kexin, Wang Lu, Marder Wendy, McCune W. Joseph, Jain Raghav, Herndon-Fenton Sidney, Hassett Afton L., Barbour Kamil E., Pestka James J., Somers Emily C.
Primary Institution: University of Michigan
Hypothesis
Investigating associations between serum fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE).
Conclusion
Increased levels of omega-3 polyunsaturated fatty acids (PUFAs), particularly DHA, are associated with better outcomes in SLE patients.
Supporting Evidence
- Omega-3 PUFAs were favorably associated with disease activity and pain.
- DHA showed the most robust favorable associations across all outcomes.
- Most participants had low omega-3 PUFA status, indicating room for dietary improvement.
- PUFAs, particularly omega-3s, may play a role in managing lupus symptoms.
Takeaway
Eating more omega-3 fatty acids, like those found in fish, can help people with lupus feel better and manage their symptoms.
Methodology
The study analyzed serum levels of 25 fatty acids in 418 SLE participants and assessed disease activity, pain, and sleep quality using standardized questionnaires.
Potential Biases
Potential biases may arise from self-reported data and the single time-point measurement of fatty acids.
Limitations
The cross-sectional design limits causal inferences, and the study's findings may not be generalizable to other populations.
Participant Demographics
Average age was 54 years, 93% female, with 54% White and 42% Black participants.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI -0.05 to -0.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website